Identification of an Imidazopyridine-based Compound as an Oral Selective Estrogen Receptor Degrader for Breast Cancer Therapy. - Pan M; Solozobova V; Kuznik NC; Jung N; Gräßle S; Gourain V; Heneka YM; Cramer von Clausbruch CA; Fuhr O; Munuganti RSN; Maddalo D; Blattner C; et al. (Cancer research communications, 2023)